Stolz J F, Marsden C A
Eur J Pharmacol. 1982 Apr 8;79(1-2):17-22. doi: 10.1016/0014-2999(82)90570-2.
Acute treatment of rats with metergoline (2 mg/kg), a serotonin antagonist, prevented the behavioural syndrome produced by the serotonin agonist 5-methoxy-N',N'-dimethyltryptamine (2.5 mg/kg, 5MEODMT). dl-Propranolol (15 mg/kg) and amitriptyline (15 mg/kg) also inhibited the behavioural syndrome. The 5MEODMT behavioural syndrome was attenuated when metergoline or amitriptyline were administered daily for 14 days and 5MEODMT administered 30 min after the injection on day 14. This attenuation was not seen with chronic dl-propranolol treatment. When 5MEODMT was administered 72 h after the last injection of metergoline, amitriptyline or dl-propranolol on day 14, the behavioural syndrome was enhanced. The results suggest that withdrawal from chronic treatment with serotonin antagonists results in functional supersensitivity of serotoninergic neurones.
用血清素拮抗剂美替麦角林(2毫克/千克)对大鼠进行急性治疗,可预防血清素激动剂5-甲氧基-N',N'-二甲基色胺(2.5毫克/千克,5MEODMT)产生的行为综合征。dl-普萘洛尔(15毫克/千克)和阿米替林(15毫克/千克)也能抑制该行为综合征。当美替麦角林或阿米替林连续14天每日给药,并在第14天注射后30分钟给予5MEODMT时,5MEODMT行为综合征会减弱。慢性dl-普萘洛尔治疗未出现这种减弱情况。当在第14天最后一次注射美替麦角林、阿米替林或dl-普萘洛尔72小时后给予5MEODMT时,行为综合征会增强。结果表明,血清素拮抗剂的慢性治疗停药会导致血清素能神经元功能超敏。